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Psychological response and quality of life after
transplantation: a comparison between heart,
lung, liver and kidney recipients
Abstract
Principles: Various non-specific questionnaires were used to measure quality of life and psychological
wellbeing of patients after organ transplantation. At present cross-organ studies dealing specifically with
the psychological response to a transplanted organ are non-existent in Germanspeaking countries.
Methods: The Transplant Effects Questionnaire TxEQ-D and the SF-36 Quality of Life Questionnaire
were used to examine the psychological response and quality of life of 370 patients after heart, lung,
liver or kidney transplantation. The organ groups were compared with regard to psychosocial
parameters. Results: 72% of patients develop a feeling of responsibility for the received organ and its
function. This feeling is even stronger towards the patient's key relationships i.e. family, friends, the
treatment team and the donor. 11.6% worry about the transplanted organ. Heart and lung patients report
significantly fewer concerns than liver and kidney patients. Overall, only a minority of patients report
feelings of guilt towards the donor (2.7%), problems in disclosing their transplant to others (2.4%), or
difficulties in complying with medical orders (3.5%). Lung transplant patients show significantly better
adherence. Conclusions: A feeling of responsibility towards those one is close to and towards the donor
is a common psychological phenomenon after transplantation of an organ. Conscious feelings of guilt
and shame are harboured by only a minority of patients. The fact that heart and lung patients worry less
about their transplant might have primarily to do with the greater medical and psychosocial support in
this group.
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Principles: Various non-specific questionnaires
were used to measure quality of life and psycho-
logical wellbeing of patients after organ trans-
plantation. At present cross-organ studies dealing
specifically with the psychological response to a
transplanted organ are non-existent in German-
speaking countries.
Methods: The Transplant Effects Question-
naire TxEQ-D and the SF-36 Quality of Life
Questionnaire were used to examine the psycho-
logical response and quality of life of 370 patients
after heart, lung, liver or kidney transplantation.
The organ groups were compared with regard to
psychosocial parameters. 
Results: 72% of patients develop a feeling of
responsibility for the received organ and its func-
tion. This feeling is even stronger towards the pa-
tient’s key relationships i.e. family, friends, the
treatment team and the donor. 11.6% worry
about the transplanted organ. Heart and lung pa-
tients report significantly fewer concerns than
liver and kidney patients. Overall, only a minority
of patients report feelings of guilt towards the
donor (2.7%), problems in disclosing their trans-
plant to others (2.4%), or difficulties in comply-
ing with medical orders (3.5%). Lung transplant
patients show significantly better adherence.
Conclusions: A feeling of responsibility towards
those one is close to and towards the donor is a
common psychological phenomenon after trans-
plantation of an organ. Conscious feelings of guilt
and shame are harboured by only a minority of
patients. The fact that heart and lung patients
worry less about their transplant might have
 primarily to do with the greater medical and
 psychosocial support in this group. 
Key words: organ transplant; psychological re-
sponse; quality of life; transplant effects questionnaire
TxEQ-D; differences between organ groups
Summary
Because of an increasing need to understand
health-related quality of life after a medical or
surgical intervention, various instruments to
measure quality of life have been developed over
the past few years in the field of psychosomatic
research. The majority of the questionnaires deal-
ing with quality of life, psychological wellbeing
and health-related behaviour were not specially
designed to address transplant-specific topics.
Moreover, instruments – if available at all – are re-
stricted to organ groups, such as the Kidney
Transplant Questionnaire (KTQ) [1], the Heart
Transplant Symptom Checklist [2], the End-
Stage Renal Disease Symptom Checklist (ESRD-
SCL) [3], or the Bone Marrow Transplantation
Symptoms List [4]. In recent years transplant-
specific instruments such as the Transplant Ef-
fects Questionnaire (TxEQ) have been developed
for the English language. This questionnaire as-
sesses the emotional response to an organ trans-
plant as well as the health behaviour of the organ
recipient, and it is suitable for all organ groups [5,
6]. Because there is no German version available
the TxEQ was translated and a validated by our
group (“Fragebogen zur psychischen Verarbeitung
einer Organtransplantation”, TxEQ-D) [7, in press]. 
Quality of life and psychological responses to
transplantation are constructs to assess different
psycho-social aspects after organ transplantation.
Quality of life is conceptualised as a self-rating
multidimensional construct with physical, mental
and social aspects comprising the psychological,
social and physical status of a subject. Quality of
life assessments are often used to evaluate the out-
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come of medical interventions. The psychological
response to transplantation reflects the subtle and
complex cognitive, emotional and behavioural
process after transplantation. For example, SF-36
assesses general psychological wellbeing (mental
health), TxEQ-D assesses feelings of guilt and re-
sponsibility against the background of the rela-
tionship with donor, family and medical staff.
Both concepts – quality of life and psychological
responses – are likely to correlate, i.e. problems in
psychological processing after transplantation
may have an effect on the subject’s quality of life.  
The comparison of organ groups allows iden-
tification of group-specific features regarding
quality of life as well as psychological processing
of transplantation experiences. An important clin-
ical issue may be to identify risk patients, thus
serving to plan and implement specific interven-
tions. On the whole there are few studies in trans-
plant medicine research which compare organ
groups. The main differences observed to date are
that heart and lung patients show the most
marked improvement in quality of life after an
organ transplant, whilst improvement is less obvi-
ous in liver and kidney patients [8–9]. Whereas
Beilby et al. [10] found no difference between the
quality of life of lung and liver transplant patients,
we noted in a prospective study that the quality of
life and mental health of liver patients worsens in
the medium term post transplantation whilst the
corresponding parameters remain stable or even
continue to improve for lung patients [11]. Ad-
mittedly, these comparisons between organ
groups were carried out with non-transplant-
specific instruments. 
Thanks to TxEQ-D it is now possible for the
first time to compare psychological responses
after a heart, lung, liver or kidney transplant. The
study asks the following questions: 1) How is the
psychological response and quality of life for
heart, lung, liver or kidney recipients after an
organ transplant? 2) What differences exist be-
tween the individual organ groups in terms of
psychological response and quality of life after an
organ transplantation? Our main hypothesis was
that emotional response as well as quality of life
will differ between organ groups.
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Methodology
Structure of study and patients
This cross-sectional study was carried out with the
approval of the Ethics Committee of University Hospital
Zurich in September 2006. It included all German-speak-
ing patients who had received a heart (since 1985, n =
111), liver (since 1987, n = 117) or lung transplant (since
1995, n = 115) at University Hospital Zurich and who
were still living. They were asked to join the study by mail
and concurrently were sent an information letter, a writ-
ten informed consent form and the questionnaire. From
the German-speaking kidney transplant patients (n =
862), electronically registered since 1992, a random sam-
ple was selected (n = 431, i.e. every second patient). To
avoid heterogeneity from the kidney and liver group only
patients with a deceased donor were included. 33 heart,
13 liver and 59 kidney patients did not respond. All in all,
41 heart patients (response rate 52.6%), 66 liver patients
(response rate 63.5%), 76 lung patients (response rate
66.1%) and 187 kidney patients (response rate 50.3%)
participated in and completed the study (total sample n =
370). 
Instruments
German version of the TxEQ Questionnaire (TxEQ-D)
The original English version of the Transplant Ef-
fects Questionnaire (TxEQ) contains 23 items with a
five-point Likert scale [5, 6]. The factor analysis of the
English questionnaire yielded the following five concep-
tually coherent factors: Worry about transplant, Guilt re-
garding the donor, Disclosure (of having undergone
transplantation), Adherence (to medical treatment) and
Responsibility (towards family, friends, medical staff
and/or towards the donor). In a validation study [6], both
the Transplant Effects Questionnaire (TxEQ) and the
Short Form Health Survey (SF-36) were used with 347
kidney transplant patients. The results of this study show
that the English TxEQ has good psychometric parame-
ters and is able to illustrate different emotional-response
types among patients after a living or deceased organ do-
nation [5, 6]. 
The German-language version TxEQ-D is available
in a validated form (for detailed translation procedure and
the validation see Klaghofer et al. [7, in press]). In con-
trast to the English validation study, the German version
(TxEQ-D) was used in a random sample of kidney trans-
plant patients (n = 187) as well as in patients from other
organ groups (heart, n = 41; lung, n = 76; liver, n = 66).
The latter were included because the original TxEQ
questionnaire contains no kidney-specific items and the
TxEQ items are related to psychological constructs such
as guilt, responsibility or health behaviour which apply to
organ transplantation irrespective of the organ type. The
validation is based on the same patient sample used to cal-
culate the organ-group differences in this article. In sum-
mary, the factorial structure and variance of the English
and German versions of the questionnaire are highly
comparable. In the German version, the values for inter-
nal consistency (Cronbach’s alpha) lie between 0.71
 (disclosure) and 0.79 (adherence); in the original English
version, Cronbach´s alpha lies between 0.72 and 0.86.
Furthermore we found substantial correlations with the
mental component scale of SF-36, but none with the
physical component scale [7].
SF-36 Health Survey (German version)
The SF-36 Health Survey [12] in the validated Ger-
man version – Fragebogen zum Gesundheitszustand SF-36
[13] – measures various areas of health-related subjective
quality of life. The multidimensional concept of the self-
assessment questionnaire takes into account the physical,
psychological and social aspects of health-related quality
of life. This internationally used instrument consists of
eight scales (Physical functioning, Role physical, Bodily pain,
General health, Vitality, Social functioning, Role emotional,
Mental health) and two sum scales (mental component
scale, physical component scale) which are weighted com-
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Sociodemographic and medical data
Tables 1a and b show the sample’s sociodemo-
graphic and medical data.
The ratio between male and female organ
 recipients is approx. 2:1. Women are markedly
under-represented in the heart transplant group.
The average time between transplant and inquiry
is longest for the heart transplant patients and
shortest for the lung transplant patients. More-
over, the latter are the youngest at the time of
both transplant and inquiry. 
Results of TxEQ-D and SF-36 
Table 2 shows means and standard deviations
of the German version of the Transplant Effects
Questionnaire (TxEQ-D) and of the SF-36
Health Survey, with significance data on the dif-
ferences between the SF-36 values of the study
population and SF-36 standard values [13], as well
as significance data on the differences between the
organ groups.
As shown in table 2, patients are moderately
worried about their transplanted organ. They ex-
perience little guilt regarding the donor, and have
no difficulty in disclosing their identity as a trans-
plant recipient. They report good adherence, and
feel moderately responsible for the transplanted
organ. 
Comparison with the standard sample of SF-
36 representing the general population [13] shows
that transplant patients come off worse in the
scales Physical functioning, Physical role function,
General perception of health, Social functioning and
479
posite scales of the eight single scales. The scales consist
of 2–10 items with 2- to 10-point Likert scales. To facili-
tate comparisons all scales are linear T-transformed
(mean = 50, SD = 10). Higher values reflect better physi-
cal, psychological or social functioning. In the German
version the internal consistency (Cronbach’s a) of the
eight SF-36 scales lies between .74 (Social functioning) and
.94 (Physical functioning).
Statistical analysis
All analyses were conducted with the program SPSS
for Windows, release 12. Descriptive statistics are given
in terms of means and standard deviations, counts and
percentages respectively. The comparisons of organ
groups were carried out by analyses of covariance (covari-
ates: age at Tx und follow-up time) followed by pairwise
comparisons according to Bonferroni. We also calculated
the rate of agreement and disagreement respectively for
each scale of the TxEQ-D by means of the scale values 
(1 = strongly disagree, 2 = disagree, 3 = uncertain, 4 =
agree, 5 = strongly agree). We compared these rates
 between organ groups by chi-square tests. Comparisons
between sample values and values of the normal commu-
nity sample were conducted by z-tests.
S W I S S  M E D  W K LY 2 0 0 8 ; 13 8 ( 3 3 – 3 4 ) : 4 7 7 – 4 8 3  ·  w w w. s m w. ch
Results
Heart (n = 41) Lung (n = 76) Liver (n = 66) Kidney (n = 187) Total (n = 370)
Sex
female 4 (10%) 33 (43%) 23 (35%) 65 (35%) Ratio male/female = 2/1
male 37 (90%) 43 (57%) 43 (65%) 122 (65%)
Age in years at FU 62.0 (24–75) 45.3 (18–68) 54.3 (24–75) 53.6 (18–78) 52.9 (18–78)
Mean (range
Age in years at Tx* 48.3 (14–65) 41.1 (14–68) 48.8 (15–68) 46.8 (13–72) 46.2 (13–72)
Mean (range)
Time in months since Tx*
Mean (range) 164 (102–239) 50 (2–131) 66 (4–229) 81 (3–163) 81 (2–239)
FU = follow up (inquiry), *Tx = transplantation
Table 1a
Sociodemographic
and medical data.
Heart (n = 41) cardiomyopathy: 18 (44%)
coronary heart disease: 16 (39%)
other diagnoses: 7 (17%)
Lung (n = 76) cystic fibrosis: 30 (40%)
chronic obstructive pulmonary disease: 26 (34%)
pulmonary fibrosis: 14 (18%)
other diagnoses: 6 (8%)
Liver (n = 66) liver cirrhosis (due to hepatitis C): 15 (23%)
liver cirrhosis (due to hepatitis B): 12 (18%)
hepatocellular carcinoma: 7 (10%)
cryptogenic liver cirrhosis: 6 (9%)
primary biliary cirrhosis 6 (9%)
postalcoholic cirrhosis: 5 (8%)
fulminant hepatic failure: 5 (8%)
other diagnoses: 10 (15%)
Kidney (n = 187) hereditary kidney diseases: 43 (23%)
chronic glomerulonephritis: 40 (21%)
diabetic nephropathy: 25 (13%)
chronic renal insufficiency: 14 (8%)
nephrosclerosis: 10 (5%)
Alport syndrome: 7 (4%)
renal dysplasia / aplasia: 7 (4%)
reflux nephropathy: 7 (4%)
hypertensive nephropathy: 6 (3%)
IGA nephropathy: 5 (3%)
pyelonephritis: 5 (3%)
other diagnoses:18 (9%)
Table 1b
Diagnoses before transplantation, ranked according 
to frequency (number, percent).
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Emotional role function as well as in the physical
sum scale. There is no difference in the scales
Bodily pain, Vitality, and Psychological wellbeing or in
the psychological sum scale.
The organ-group comparison in table 2
shows that in the scale Worry about transplant
there is a significant difference between the organ
groups heart/lung and kidney, as well as between
the liver and lung group. Heart and lung trans-
plant patients worry less about the transplanted
organ than patients after kidney transplant, and
lung transplant patients worry less than liver
transplant patients. Moreover, lung transplant pa-
tients claim a significantly higher adherence than
the other organ groups, and – at least in compari-
son with kidney transplant patients – feel less
guilt. In the Disclosure of recipient status and Re-
sponsibility scales, there are no significant differ-
ences between organ groups. 
When questioned on quality of life, lung pa-
tients achieve significantly higher values in the
SF-36 scale Role emotional than all other organ
groups. Lung patients have a significantly higher
score in the mental component scale than liver
and kidney patients. All in all, lung patients show
the most favourable scores for self-assessment of
quality of life in all of the SF-36 scales with sig-
nificant differences in some of the psychological
scales.
Table 3 shows the absolute and relative fre-
quencies of patients who assert (= 1) or deny (= 0)
that they worry about the transplant (>3.5 on the
5-point Likert scale), feel guilty (>3.5), have prob-
lems disclosing that they are transplant recipients
(<2.5), have low adherence (<2.5) or a low sense of
responsibility (<2.5), both overall and when split
into individual organ groups. Moreover, data on
the statistical significance of the differences be-
tween the organ groups are indicated.
As may be gathered from table 3, 11.6% of
the patients admit to worry about the transplant.
Only a minority (2.7%) report feelings of guilt to-
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Scales Organ groups
Total1 Heart Lung Liver Kidney
M (SD) M (SD) M (SD) M (SD) M (SD) p2 Norm p3 Groups Bonferroni3
TxEQ-D
Worry 2.56 (.70) 2.20 (.67) 2.30 (.66) 2.60 (.98) 2.74 (.82) –4 <.001 K> H, Lu5
Li> Lu
Guilt 1.71 (.84) 1.56 (.66) 1.56 (.63) 1.78 (.79) 1.79 (.70) – .037 K> Lu
Disclosure 4.42 (.73) 4.23 (.71) 4.43 (.76) 4.46 (.81) 4.45 (.70) – .102 –
Adherence 4.35 (1.06) 4.27 (.79) 4.71 (.43) 4.07 (.89) 4.32 (.74) – <.001 Lu > H, Li, K
Responsibility 3.00 (.73) 2.95 (1.00) 3.06 (1.00) 3.07 (1.13) 2.96 (1.07) – .832 –
SF-36 
Physical 47.11 (9.71) 46.21 (9.57) 49.77 (7.93) 45.83 (9.85) 46.7 (10.21) <.001 .523
functioning
Role physical 45.88 (11.97) 44.02 (12.49) 49.94 (10.02) 44.25 (12.66) 45.24 (12.04) <.001 .061 –
Bodily pain 50.54 (11.71) 46.68 (12.06) 53.28 (9.90) 49.48 (12.02) 50.63 (12.01) ns .346 –
General health 45.13 (10.52) 44.50 (8.78) 46.43 (9.15) 46.12 (11.55) 44.39 (10.99) <.001 .567 –
Vitality 49.02 (10.92) 49.18 (10.46) 51.95 (9.30) 47.03 (12.27) 48.49 (10.96) ns .090 –
Social functioning 48.96 (10.88) 48.96 (10.56) 52.31 (8.19) 48.16 (12.03) 47.87 (11.28) <.05 .059 –
Role emotional 49.24 (10.58) 49.28 (10.53) 52.61 (7.20) 47.28 (11.92) 48.52 (11.02) <.05 .004 Lu > H, Li, K
Mental health 49.79 (10.60) 50.91 (9.13) 52.12 (10.91) 48.71 (11.85) 48.97 (10.22.) ns .059 –
Physical component scale 46.49 (10.63) 43.47 (10.49) 49.10 (8.77) 45.78 (10.90) 46.34 (11.09) <.001 .831 –
Mental component scale 50.28 (10.34) 51.73 (7.56) 52.82 (9.74) 48.65 (11.85) 49.51 (10.37) ns .005 Lu > Li, K
1 TxEQ-D / SF-36 mean values and standard deviations of the whole sample according to Klaghofer et al. [7]; 
2 differences between study results and SF-36 norm values (M = 50, SD = 10); 3 differences between organ groups; 
4 TxEQ-D norm values are not available; 5 Abbreviations: H = heart, Lu = lung, Li = liver, K = kidney
Table 2
Means and standard deviations of the  German version of the Transplant Effects Questionnaire (TxEQ-D) and of the SF-36 Health Survey, with signifi-
cance data on the differences between the SF-36 values of the study population and the SF-36 norm values [13] as well as significance data on the
 differences between the organ (n = 370); analyses of covariance, covariates: age at transplantation and follow-up time after transplantation.
Organ groups
TxEQ-D Total Heart Lung Liver Kidney p1
Worry 43 1 3 12 27 .008
11.6% 2.4% 3.9% 18.2% 14.4%
Guilt 10 1 2 2 5 .998
2.7% 2.4% 2.6% 3.0% 2.7%
Disclosure 9 1 2 3 3 .616
2.4% 2.4% 2.6% 4.5% 1.6%
Adherence 13 1 0 4 8 .213
3.5% 2.4% .0% 6.1% 4.3%
Responsibility 104 12 16 19 57
28.1% 29.3% 21.1% 28.8% 30.5% .487
1 Significance on differences between the organ groups
Table 3
Absolute and relative
frequencies of pa-
tients who assert 
(= 1) or deny (= 0)
that they worry about
the transplant (>3.5
on the 5-point Likert
scale), feel guilty
(>3.5), have problems
disclosing that they
are transplant recipi-
ents (<2.5), have low
adherence (<2.5) or a
low sense of respon-
sibility (<2.5), overall
and broken down
into individual organ
groups, and provid-
ing significance data
on the differences 
between the organ
groups (n = 370).
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wards the donor, problems with disclosure of
their recipient status (2.4%), or low adherence
(3.5%). 72% of the patients report that they feel
responsible towards their treatment team, family,
friends, and the donor, in regard to the function-
ing of the transplanted organ. 
The organ-group comparison in terms of the
frequency with which transplant-specific forms of
response (TxEQ-D) are given, as shown in Table
3, reveals that significantly more liver and kidney
patients worry about the transplanted organ com-
pared with recipients of a heart or lung.
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Discussion
In this study we investigated how organ recip-
ients responded to their transplant, what sort of
quality of life they experienced, and in what areas
differences between different organ groups ex-
isted. Whereas previous studies consistently
showed that quality of life substantially improves
after organ transplantation, and can even achieve
the scores of general population samples [8, 10,
14–18], to date few findings exist on how the dif-
ferent organ groups respond psychologically to
the transplant. Thus far only two studies based on
relatively small samples have been published on
this subject [19, 20]. For quantitative assessment
of the psychological response to an organ trans-
plant, we translated the Transplant Effect Ques-
tionnaire TxEQ developed by Ziegelmann et al.
[5] into German. Using TxEQ-D as well as the
SF-36 Quality of Life Survey for several organ
groups, we compared different organs in terms of
the psychological response to a transplant and
quality of life. 
In the total group of recipients we found that
patients worry to a moderate extent about their
transplant (M = 2.56 on a 5-point Likert scale), ex-
perience little guilt regarding the donor (M =
1.71), and do not shy away from disclosing their
identity as a transplant recipient (M = 3.42). They
also report good adherence (M = 4.35) and feel re-
sponsible towards family members, friends, their
treatment team and/or the donor of the trans-
planted organ (M = 3.0). Accordingly, the number
of patients who feel guilt in regard to the donor
and shame when revealing their status as a trans-
plant recipient is very low. By the same token,
72% of all patients state that they would feel re-
sponsible towards their family, friends and treat-
ment team, but also towards the donor, as regards
the functioning of their transplanted organ. At the
same time the frequency of sound medical adher-
ence lies markedly above 90%. On the back-
ground to these statements it must be borne in
mind that (1) the response rate for the study is
slightly under 60% and (2) that among those who
declined to take part in the study the number of
patients with low adherence was possibly quite
high, thus leading to a bias in the estimation of
treatment adherence. Moreover, response behav-
iour may be influenced by social desirability, with
patients in any case affirming that they take their
medication. 
In sum, few patients reported emotional diffi-
culties in processing an organ transplantation.
Most of them exhibited good health behaviour
(adherence) and a feeling of responsibility. We
conclude that the overwhelming majority of
organ transplant patients evince a mature psycho-
logical response to the organ transplant, and only
a small minority report specific problems in han-
dling the new situation after transplantation.
The organ group comparison reveals an im-
portant and surprising result – namely, that heart
and lung transplant patients worry significantly
less about the transplanted organ than patients
after liver or kidney transplantation. This result is
surprising, since the risk of medical complications
(such as pulmonary infection) is particularly high
after a lung transplant. There are various possible
explanations for this result: both lung and heart
transplant patients probably perceive themselves
as more at risk in health terms than the other
organ groups. However, due to psychological de-
fence mechanisms, e.g. risk denial or affect isola-
tion, these patients scarcely report conscious wor-
ries about the transplanted organ. An additional
factor may be that both heart and lung transplant
patients receive particularly intensive medical and
psychosocial treatment which counteracts worries
about the new heart or lung. We presented the re-
sults of our study in an information seminar
framework for lung transplant patients and their
family members at which lectures are regularly
given on relevant research results. The discussion
showed that family members were likely to attrib-
ute the relatively slight fears of their transplant-
recipient partners to the latter’s disengagement
from their feelings. The patients themselves, on
the other hand, pointed to the advantages of a
closely meshed follow-up treatment providing
feelings of security. 
For the rest, there are no differences between
the organ groups in the TxEQ scales Feelings of
guilt, Disclosure of one’s transplant-recipient status,
and Responsibility. Comparable processing mecha-
nisms evidently take place in the different organ
groups in these areas. The comparison of the SF-
36 scores shows that lung patients also report the
highest scores in the mental component scale
dealing with the totality of psychological quality
of life. We think the fact that these patients were
most severely threatened before transplantation,
and thus benefit most in terms of health improve-
ment and relief, accounts for their good perform-
ance [10]. 
477-483 Goetz 12160.qxp  15.8.2008  11:36 Uhr  Seite 481
Limitations of the study
The most important limitation of the study is
the 60% response rate. On the one hand this can
be ascribed to the fact that the invitation for par-
ticipation in the study was only sent by mail and
no personal contact was established with the sub-
jects.  On the other hand our return is comparable
to the the rates commonly seen in psychosocial
studies. It must be assumed, however, that pa-
tients with non-adherence behaviour, or those
who have trouble processing their transplants are
more likely to be found among the non-partici-
pants. On the background of the fact that non-ad-
herence can be linked to the rate of non-partici-
pation this clearly is a selection bias. Beside this
argument, participants may also report good ad-
herence because this health behaviour is strongly
desired and socially more accepted. Moreover, it
is conceivable that patients, who have problems
with their new identity as expressed by their diffi-
culty to disclose themselves as transplant recipi-
ents, are unlikely to participate in a psychosocial
study. This selection bias could also have influ-
enced the results of our study. There are two ad-
ditional limitations: to limit the extent of the
questionnaire, no further sociodemographic data
such as the patient’s education or professional
 status, etc., were collected. Also, in line with the
psychosocial objectives of this investigation, no
further clinical data (such as number of rejections,
morbidity) were used.
482Psychological response and quality of life after transplantation: a comparison between heart, lung, liver and kidney recipients
Conclusions
We conclude that during follow-up liver and
kidney transplant patients in particular should be
actively questioned about their worries concern-
ing the transplanted organ and the concerns dis-
cussed with the patients and their families. Studies
on the psychological response to an organ trans-
plant should concentrate primarily on patients
with difficult long-term courses, especially with
regard to the question of how dysfunctional re-
sponses can be corrected by means of psychosocial
or psychotherapeutic interventions. 
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ADDENDUM
Fragebogen zur psychischen Verarbeitung
einer Organtransplantation (TxEQ-D)
Mit diesem Fragebogen interessieren wir uns
für Ihre persönliche Beurteilung, wie Sie heute
Ihre Erfahrungen mit der Organtransplantation
sehen. Im Folgenden finden Sie Aussagen, die an-
dere Personen über ihre Transplantation gemacht
haben. Schätzen Sie bitte das Ausmass ein, mit
dem Sie den Aussagen zustimmen bzw. nicht zu-
stimmen, indem sie das entsprechende Kästchen
ankreuzen.
stimmt stimmt unsicher, stimmt stimmt über-
völlig ob es stimmt nicht haupt nicht
1 Was mein transplantiertes Organ angeht, habe ich  das Gefühl, r1 r2 r3 r4 r5
dass ich etwas Zerbrechliches mit mir herumtrage.
2 Manchmal denke ich, dass ich meine Medikamente gegen r1 r2 r3 r4 r5
die Abstossung nicht brauche.
3 Ich zögere, bei bestimmten Aktivitäten mitzumachen, weil ich r1 r2 r3 r4 r5
Angst habe, dass ich meinem transplantierten Organ schaden 
könnte.
4 Ich denke, ich habe gegenüber dem Transplantationsteam r1 r2 r3 r4 r5
die Verantwortung, dass alles gut geht.
5 Ich fühle mich unwohl in Gegenwart anderer Leute, r1 r2 r3 r4 r5
die wissen, dass ich transplantiert bin.
6 Ich habe das Gefühl, dass ich dem Spender bzw. der Familie  r1 r2 r3 r4 r5
des Spenders etwas schulde, das ich nie zurückbezahlen kann.
7 Manchmal vergesse ich, meine Medikamente gegen die r1 r2 r3 r4 r5
Abstossung einzunehmen.
8 Ich habe dem Spender gegenüber keine Schuldgefühle. r1 r2 r3 r4 r5
9 Ich mache mir Sorgen, dass ich mein transplantiertes Organ r1 r2 r3 r4 r5
beschädigen könnte.
10 Ich denke, ich habe gegenüber dem Spender / der Familie r1 r2 r3 r4 r5
des Spenders die Verantwortung, dass alles gut geht.
11 Ich finde es schwierig, mich an die vorschriftsmässige r1 r2 r3 r4 r5
Einnahme der Medikamente zu gewöhnen.
12 Ich beobachte meinen Körper genauer als vor der Transplantation. r1 r2 r3 r4 r5
13 Es fällt mir schwer, über meine Transplantation zu sprechen. r1 r2 r3 r4 r5
14 Ich habe Schuldgefühle, dass ich von der Situation des r1 r2 r3 r4 r5
Spenders profitiert habe.
15 Ich vermeide es, anderen Leuten zu sagen, dass ich r1 r2 r3 r4 r5
transplantiert bin.
16 Ich mache mir jedes Mal Sorgen, wenn mein Arzt etwas r1 r2 r3 r4 r5
an meinen Medikamenten ändert.
17 Der Spender musste leiden, damit es mir jetzt besser geht. r1 r2 r3 r4 r5
18 Es beschäftigt mich ständig, wie lange das r1 r2 r3 r4 r5
transplantierte Organ funktionieren wird.
19 Manchmal denke ich, dass ich dem Spender etwas r1 r2 r3 r4 r5
Lebenswichtiges «geraubt» habe.
20 Wenn ich zu sehr beschäftigt bin, kann es vorkommen, r1 r2 r3 r4 r5
dass ich meine Medikamente gegen die Abstossung vergesse.
21 Ich denke, ich habe gegenüber meinen Freunden und r1 r2 r3 r4 r5
meiner Familie die Verantwortung, dass alles gut geht.
22 Manchmal nehme ich meine Medikamente gegen die r1 r2 r3 r4 r5
Abstossung nicht ein.
23 Ich habe das Gefühl, dass der Spender / die Familie des r1 r2 r3 r4 r5
Spenders irgendwie Kontrolle über mich ausübt.
Scoring: To achieve comparability with the original version in English we scored with the following procedure:
1. Recode items 1, 3, 4, 6, 8, 10, 12, 16 to 19, 21, 23 (1 = 5) (2 = 4) (3 = 3) (4 = 2) (5 = 1)
2. Calculate scale value for “guilt regarding donor” = sum score of items 8, 14, 17, 19 and 23, divided through 5
Calculate scale value for “worry about transplant” = sum score of items 1, 3, 9, 12, 16 and 18, divided through 6
Calculate scale value for “adherence” = sum score of items 2, 7, 11, 20 and 22, divided through 5
Calculate scale value for “responsibility” = sum score of items 4, 6, 10 and 21, divided through 4
Calculate scale value for “disclosure” = sum score of items 5, 13 and 15, divided through 3
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